BioRestorative Therapies (BRTX) Live Share Price, Invest From India

BioRestorative Therapies Stock Performance

as on August 29, 2026 at 2:15 pm IST

Day's High
$0.20
Day's Price Range
$0.22
$0.20
10.00%
Upside
52 Week's Low
52 Week's High
$0.16
52-Week Price Range
$1.89
$0.20
20.35%
Downside
845.00%
Upside

BioRestorative Therapies share price movements today

Previous Close: $0.21
Open: $0.22
Volume: 928.2K
Market Cap: $5.2M
Day's Low - High: $0.20 - $0.22
52 Week Low - High: $0.16 - $1.89

BioRestorative Therapies Historical Returns

1 Month Return: -22.73 %
3 Month Return: -56.99 %
1 Year Return: -88.74 %
3 Year Return: -91.42 %
5 Year Return: 0 %

BioRestorative Therapies Stock Fundamentals & Key Indicators

Check BioRestorative Therapies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.2M

EPS (TTM)

-0.66

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-14.0M

Revenue (TTM)

357.9K

Profit Margin

0.00%

Return On Equity TTM

-241.14%

BioRestorative Therapies vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioRestorative Therapies with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BioRestorative Therapies	BUY	$5.2M	NA	NA	0.00%	NA
Revolution Medicines	BUY	$46.2B	675.69%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$138.7B	173.88%	31.92	86.04%	NA
Moderna	BUY	$59.7B	-62.65%	-7.98	-12.57%	NA
Regeneron	BUY	$85.8B	21.77%	19.9	84.86%	0.44%

Stock Returns calculator for BioRestorative Therapies Stock including INR - Dollar returns

The BioRestorative Therapies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

BioRestorative Therapies investment value today

Current value as on today

₹11,829

Returns

-₹88,171

(-88.17%)

Returns from BioRestorative Therapies Stock

-₹89,065 (-89.07%)

Dollar Impact

₹894 (+0.89%)

Analyst Recommendation on BioRestorative Therapies Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for BioRestorative Therapies. Average target price of $8

BioRestorative Therapies Share Price Target

Get share price movements and forecasts by analysts on BioRestorative Therapies.

What analysts predicted

97.5%UPSIDE

Target Price

Current Price

$0.2

Analyzed by

8 Analysts

Target

$8.00

BioRestorative Therapies target price $8, a slight upside of 97.5% compared to current price of $0.2. According to 8 analysts rating.

Indian Investors' Interest in BioRestorative Therapies Stock

Search interest for BioRestorative Therapies Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 31, 2026 to August 30, 2026

Change:16% versus previous 30 day period

BioRestorative Therapies Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	-	0	0	0	0	0	0	0	0	0
Operating Income	-3	-4	-2	-2	-2	-4	-3	-3	-3	-3
EBITDA	-	-2	-3	-1	-1	-5	-2	-2	-3	-2
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	-4	-1	-1	-5	-2	-3	-3	-2
Income Tax Expense	-	0	0	-	0	-	-	-	-	-
Net Income	-2	-2	-4	-1	-1	-5	-2	-3	-3	-2
Net Profit Margin	-14638.44%	-6352.16%	-4521.39%	-467.22%	-3778.63%	-21359.20%	-875.79%	-25748.11%	-16365.49%	-9298.25%

BioRestorative Therapies Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	-	0	0	0	0	0	0
Operating Income	-7	-8	-7	-8	-2	-26	-18	-15	-11	-15
EBITDA	-7	-8	-9	-9	-9	-42	-13	-14	-8	-14
Interest Expense	0	1	3	5	1	1	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-9	-12	-14	-11	-44	-13	-10	-8	-14
Income Tax Expense	0	1	-1	-	3	-14	0	0	-	-
Net Income	-8	-9	-12	-14	-11	-44	-13	-10	-8	-14
Net Profit Margin	-23755.44%	-11660.07%	-11277.30%	-11267.61%	-14639.85%	-96311.51%	-11036.97%	-7145.20%	-2239.25%	-3959.40%

BioRestorative Therapies Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-4	-1	-1	-5	-2	-3	-3	-2
Operating Cash Flow	-2	-1	-1	-2	-2	-2	-2	-2	-3
Investing Cash Flow	-4	2	0	1	2	2	1	2	0
Financing Cash Flow	7	0	-	0	1	0	0	0	4
Change in Cash	0	1	0	0	0	0	0	0	1

BioRestorative Therapies Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-12	-14	-11	-44	-13	-10	-8	-14
Operating Cash Flow	-3	-5	-6	-1	-3	-5	-6	-8	-10
Investing Cash Flow	0	0	0	0	0	-13	3	0	8
Financing Cash Flow	4	4	6	5	21	21	2	7	2
Change in Cash	0	0	0	3	17	-19	0	0	0

Mutual Funds that own BioRestorative Therapies Stock

Check out the Mutual Funds with significant holdings in BioRestorative Therapies.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.217205%	55340

Global Institutional Holdings in BioRestorative Therapies

Funds	Holdings
Vanguard	0.15%

Insights on BioRestorative Therapies

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 11.8K → 23.17K (in $), with an average increase of 27.6% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.20M → -2.15M (in $), with an average increase of 48.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 562.0%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 18.3% return, outperforming this stock by 109.9%
NEGATIVE IMPACT
Price Dip
In the last 3 months, BRTX stock has moved down by -58.3%

About BioRestorative Therapies

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.

Organisation	BioRestorative Therapies
Headquarters	40 Marcus Drive, Melville, NY, United States, 11747
Industry	Biotechnology
CEO	Ms. Katharyn Field
E-voting on shares	Click here to vote

Key Management of BioRestorative Therapies

Name	Title
Mr. Francisco J. Silva	VP of Research & Development, Secretary & Chief Scientist
Ms. Katharyn Field	President, CEO, Interim CFO, Treasurer & Secretary and Director
Ms. Crystal Romano	Head of Global Commercial Operations

FAQs

What is BioRestorative Therapies share price today?

BioRestorative Therapies share price today is $0.20 as on August 29, 2026 at 8:45 am IST at the close of the market. BioRestorative Therapies share today touched a day high of $0.22 and a low of $0.20.

What is the 52 week high and 52 week low for BioRestorative Therapies share?

BioRestorative Therapies share touched a 52 week high of $1.89 on August 29, 2025 and a 52 week low of $0.16 on May 20, 2026. BioRestorative Therapies stock price today i.e. August 29, 2026 at 8:45 am IST is closed at $0.20,which is 89.42% down from its 52 week high and 25.55% up from its 52 week low.

What is BioRestorative Therapies's market capitalisation today?

BioRestorative Therapies market capitalisation is $0.00T as on August 29, 2026 at 8:45 am IST.

How to invest in BioRestorative Therapies Stock (BRTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BioRestorative Therapies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioRestorative Therapies Shares that will get you 7.5000 shares as per BioRestorative Therapies share price of $0.20 per share as on August 29, 2026 at 8:45 am IST.

What is the minimum amount required to buy BioRestorative Therapies Stock (BRTX) from India?

Indian investors can start investing in BioRestorative Therapies (BRTX) shares with as little as ₹95.38 or $1 (as of August 30, 2026 at 10:52 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in BioRestorative Therapies stock (as per the Rupee-Dollar exchange rate as on August 30, 2026 at 10:52 am IST). Based on BioRestorative Therapies share’s latest price of $0.20 as on August 29, 2026 at 8:45 am IST, you will get 50.0000 shares of BioRestorative Therapies. Learn more about fractional shares .